Navigation Links
Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
Date:2/17/2009

made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2007. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.

http://www.sanofipasteur.com

http://www.sanofipasteur.us


'/>"/>
SOURCE Sanofi Pasteur
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
2. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
3. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
4. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
5. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
6. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
7. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
8. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
9. Presbyterian Hospital Dallas Starts Advanced Breast-Cancer Risk-Assessment Program
10. U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
11. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014   OTEMR, Inc. , ONETOUCH EMR, ... certification, which designates that the software is capable of ... Stage 2 Meaningful Use measures required to qualify for ...  ONETOUCH EMR 2.0 was certified on July 14, 2014 ... National Coordinator-Authorized Certification Body (ONC-ACB) and is compliant in ...
(Date:9/17/2014)... 2014  Members of the physician IT team ... announced today that the enterprise is working with ... sharing capabilities and provide immediate cluster fail over ... addition, the Dicom Systems enterprise imaging solutions will ... to more effectively deliver the right images to ...
(Date:9/17/2014)... 2014 Women everywhere know how frustrating a ... uncomfortable, they,re often also embarrassing and have a way ... Support ( http://ph-defense.com ) is a new, over-the-counter product ... homeopathic product. Odor, discharge, and discomfort ... infection. In many cases, the cause of such problems ...
Breaking Medicine Technology:OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 2OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 3Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 2Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 3New Product from Vireo Systems: pH-D Feminine Health Support 2
... 2012  Ambit Biosciences and Teva Pharmaceutical Industries Limited (NASDAQ: ... of an Investigational New Drug application (IND)  with the U.S. ... (V600E) kinase inhibitor.  The IND filing ... as evidenced by data revealed in recent publications in ...
... - Atu027, a First in Class RNAi Therapy, Demonstrates Potential ... Biomarker Identified Silence Therapeutics to Announce New Data ... 2012 ASCO Annual Meeting Silence Therapeutics plc (AIM: ... (RNAi) therapeutics company, today announces that top line data from ...
Cached Medicine Technology:Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor 2Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor 3Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor 4Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor 5New Data from Silence's Atu027 Anticancer Trial Published at ASCO 2New Data from Silence's Atu027 Anticancer Trial Published at ASCO 3New Data from Silence's Atu027 Anticancer Trial Published at ASCO 4New Data from Silence's Atu027 Anticancer Trial Published at ASCO 5
(Date:9/17/2014)... PROVIDENCE, R.I. [Brown University] As Congress adjourns this ... bills senators will step over on their way out ... (SGR) Repeal and Medicare Provider Payment Modernization Act of ... JAMA Surgery , Dr. Eli Adashi recounts what he ... originally bipartisan bill. The perennial trouble with how Medicare ...
(Date:9/17/2014)... New York, New York (PRWEB) September 17, 2014 ... ) filings involving the Conserve line of metal-on-metal ... litigation now underway in U.S. District Court, Northern ... to an updated Case List issued by the ... 15, 2014, at least 397 product liability claims ...
(Date:9/17/2014)... Boston, MA (PRWEB) September 17, 2014 ... have partnered to create a monthly concert series, ... arts organization From the Top, America’s premier national ... classically-trained young musicians. Many of the young musicians ... the Top. , “Boston Children’s Museum is fortunate ...
(Date:9/17/2014)... TX (PRWEB) September 17, 2014 Smart ... Editor’s Picks by Progressive Grocer, a leading trade magazine ... was awarded for originality and flavor, among other attributes. ... as an Editor’s Pick in the September print issue ... Grocer website. , The pizza won based on its ...
(Date:9/17/2014)... 17, 2014 StartX , a ... companies raising rounds of funding at its Summer Demo ... investors and media, was the first such gathering held ... to the university. The presentations were delivered on an ... StartX-QB3 Labs, a 2,000 square foot life science facility ...
Breaking Medicine News(10 mins):Health News:Failed Medicare payments law remains relevant 2Health News:Failed Medicare payments law remains relevant 3Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 3Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 2Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 3Health News:Smart Flour Foods Wins 2014 Progressive Grocer Editor’s Pick Award 2Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 2Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 3Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 4Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 5Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 6
... to present findings at AMCP Conference in AprilST. ... Prime Therapeutics (Prime) revealed a significant reduction in ... a retrospective drug utilization review (RetroDUR) program paired ... research was recently published in the American Journal ...
... healing time and pain reduction, , , TUESDAY, April 14 ... production of stem cells appears to "jump-start" the bone-healing ... as fast as young people,s, suggest preliminary results released ... University of Rochester Medical Center in New York gave ...
... Expects to qualify for 180 days of sole marketing ... MYL ) today confirmed that the company and its ... Roche Inc. in connection with the filing of an ... and Drug Administration (FDA) for Capecitabine Tablets, 150 mg ...
... Pearl of Wisdom to Help Prevent Cervical Cancer UPPER MARLBORO, Md., ... knows about and benefits from the tools - the Pap test, ... from this disease. That,s the message that the Pearl of Wisdom(TM) ... women to get - and share - in honor of Mother,s ...
... Versus 2008 First Quarter; , EPS was $1.26, Equal to ... Johnson (NYSE: JNJ ) today announced sales of ... of 7.2% as compared to the first quarter of 2008. ... was 6.0%. Domestic sales declined 5.0%, while international sales declined ...
... The American Federation for Medical Research (AFMR) today has ... sectors to take action against the crisis in U.S. ... major U.S. government agencies, corporations and leading academic institutions ... clinical research from advancing in America. This lack of ...
Cached Medicine News:Health News:Drug Utilization Review Reveals Potentially Inappropriate Medication Use Among Elderly Population 2Health News:Drug Utilization Review Reveals Potentially Inappropriate Medication Use Among Elderly Population 3Health News:Slow-Healing Bones May Get Boost From Drug 2Health News:Slow-Healing Bones May Get Boost From Drug 3Health News:Mylan Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment 2Health News:Women's Health Advocates To Moms: We Can Beat Cervical Cancer! 2Health News:Women's Health Advocates To Moms: We Can Beat Cervical Cancer! 3Health News:Women's Health Advocates To Moms: We Can Beat Cervical Cancer! 4Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 2Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 3Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 4Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 5Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 6Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 7Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 8Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 9Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 10Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 11Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 12Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 13Health News:The American Federation for Medical Research Unites Top Leaders to Mitigate U.S. Crisis in Clinical Research 2
The Becton™ Colles Fracture Plate has proven clinical outcomes and has excellent patient acceptance compared to external fixation. It provides a cost effective treatment option through a simple...
Standard Trephine...
Coronet Vacuum Trephine - All metal, ergonomic design and ultra sharp blade with cross hairs....
Long Handled Trephine...
Medicine Products: